These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 1370253)
1. Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxins. Mittrücker HW; Fleischer B Cell Immunol; 1992 Jan; 139(1):108-17. PubMed ID: 1370253 [TBL] [Abstract][Full Text] [Related]
2. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977 [TBL] [Abstract][Full Text] [Related]
3. The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways. Westphal JR; Willems HW; Tax WJ; Koene RA; Ruiter DJ; de Waal RM Transpl Immunol; 1993; 1(3):183-91. PubMed ID: 7521739 [TBL] [Abstract][Full Text] [Related]
5. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290 [TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins. Bierer BE; Golan DE; Brown CS; Herrmann SH; Burakoff SJ Eur J Immunol; 1989 Apr; 19(4):661-5. PubMed ID: 2471647 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of T cell activation and adhesion functions by soluble CD2 protein. Rabin EM; Gordon K; Knoppers MH; Luther MA; Neidhardt EA; Flynn JF; Sardonini CA; Sampo TM; Concino MF; Recny MA Cell Immunol; 1993 Jun; 149(1):24-38. PubMed ID: 7685660 [TBL] [Abstract][Full Text] [Related]
8. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation. Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259 [TBL] [Abstract][Full Text] [Related]
9. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition. Makgoba MW; Sanders ME; Shaw S Immunol Today; 1989 Dec; 10(12):417-22. PubMed ID: 2482743 [TBL] [Abstract][Full Text] [Related]
10. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells. Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126 [TBL] [Abstract][Full Text] [Related]
11. The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells. Tiefenthaler G; Hünig T Int Immunol; 1989; 1(2):169-75. PubMed ID: 2484882 [TBL] [Abstract][Full Text] [Related]
12. Requirement for both the CD3/T cell receptor complex and the CD2/lymphocyte function-associated antigen-3 adhesion system in monocyte-independent T cell activation by oxidized erythrocytes. Prince HE Immunol Invest; 1989; 18(9-10):1081-93. PubMed ID: 2482251 [TBL] [Abstract][Full Text] [Related]
13. Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling. Wingren AG; Dahlenborg K; Björklund M; Hedlund G; Kalland T; Sjögren HO; Ljungdahl A; Olsson T; Ekre HP; Sansom D J Immunol; 1993 Aug; 151(3):1328-36. PubMed ID: 7687629 [TBL] [Abstract][Full Text] [Related]
14. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. Miller GT; Hochman PS; Meier W; Tizard R; Bixler SA; Rosa MD; Wallner BP J Exp Med; 1993 Jul; 178(1):211-22. PubMed ID: 7686212 [TBL] [Abstract][Full Text] [Related]
15. The LFA-3 adhesion pathway is differently utilized by superantigen-activated human CD4+ T-cell subsets. Gjörloff A; Hedlund G; Kalland T; Sansom D; Fischer H; Trowsdale J; Sjögren HO; Dohlsten M Scand J Immunol; 1992 Aug; 36(2):243-50. PubMed ID: 1380180 [TBL] [Abstract][Full Text] [Related]
16. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Weber F; Meinl E; Aloisi F; Nevinny-Stickel C; Albert E; Wekerle H; Hohlfeld R Brain; 1994 Feb; 117 ( Pt 1)():59-69. PubMed ID: 7511974 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma. Chong AS; Staren ED; Scuderi P Cancer Immunol Immunother; 1992; 35(5):335-41. PubMed ID: 1382856 [TBL] [Abstract][Full Text] [Related]
18. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response. Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326 [TBL] [Abstract][Full Text] [Related]
19. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes. Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070 [TBL] [Abstract][Full Text] [Related]
20. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions. Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]